Antipsychotics Do Not Have To Be Used "Off Label" in Dementia

Journal of the American Medical Directors Association

Volumn 13, Issue 6, 2012, Pages 495-496

  Volicer, Ladislav ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINESTERASE INHIBITOR; MEMANTINE; MOOD STABILIZER; NEUROLEPTIC AGENT; PRAZOSIN; SERTRALINE;

AGED; ALZHEIMER DISEASE; BEHAVIOR; BEHAVIOR THERAPY; COGNITIVE THERAPY; DEMENTIA; DEPRESSION; DRUG APPROVAL; DRUG COST; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR DEPRESSION; MEDICARE; NURSING HOME PATIENT; OFF LABEL DRUG USE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REIMBURSEMENT; SYMPTOM;

EID: 84862842779     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2012.04.006     Document Type: Editorial

References (30)

1. Ballard C., Creese B., Corbett A., et al. Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opin Drug Saf 2012, 10:35-43.
2. Centers for Medicare and Medicaid Services. MDS Quality Measure/Indicator Report, Psychotropic Drug Use, July/September 2010. , accessed 3/2012. http://www.medicareadvocasy.org/2011/03/17/reducing-antipsychotic-drug-use-in-nursing-hokmes-save-residents-lives-save-medicare-billions-of-dollars.
3. Department of Health and Human Services, OOIG. Medicare atypical antipsychotic drug claims for elderly nursing home residents. , accessed 3/2012. http://oig.hhs.gov/oei/reports/oei-07-08-00150.pdf.
4. Cohen-Mansfield J., Jensen B. Assessment and treatment approaches for behavioral disturbances associated with dementia in the nursing home: self-report of physicians' practices. J Am Med Dir Assoc 2008, 9:406-413.
5. Sultzer D.L., Davis S.M., Tariot P.N., et al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008, 165:844-854.
6. Hansen R.A., Gartlehner G., Webb A.P., et al. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Clin Interv Aging 2008, 3:211-225.
7. Maidment I.D., Fox C.G., Boustani M., et al. Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis. Ann Pharmacother 2012, 42:32-38.
8. Konovalov S., Muralee S., Tampi R.R. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: A literature review. Int Psychogeriatr 2008, 20:293-308.
9. Wang L.Y., Shofer J.B., Rohde K., et al. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry 2009, 17:744-751.
10. Talerico K.A., Evans L.K., Strumpf N.E. Mental health correlates of aggression in nursing home residents with dementia. Gerontologist 2002, 42:169-177.
11. Lyketsos C.G., Steele C., Galik E., et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999, 156:66-71.
12. Menon A.S., Gruber-Baldini A.L., Hebel J.R., et al. Relationship between aggressive behaviors and depression among nursing home residents with dementia. Int J Geriatr Psychiatry 2001, 16:139-146.
13. Gruber-Baldini A.L., Zimmerman S., Boustani M., et al. Characteristics associated with depression in long-term care residents with dementia. Gerontologist 2005, 45:50-55.
14. Prado-Jean A., Couratier P., Druet-Cabanas M., et al. Specific psychological and behavioral symptoms of depression in patients with dementia. Int J Geriatr Psychiatry 2010, 25:1065-1072.
15. Leonard R., Tinetti M.E., Allore H.G., et al. Potentially modifiable resident characteristics that are associated with physical or verbal aggression among nursing home residents with dementia. Arch Intern Med 2006, 166:1295-1300.
16. Volicer L., Van der Steen J.T., Frijters D.H. Modifiable factors related to abusive behaviors in nursing home residents with dementia. J Am Med Dir Assoc 2009, 10:617-622.
17. Lanctot K.L., Herrmann N., Eryavec G., et al. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology 2002, 27:646-654.
18. Yamamoto T., Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons. Ann Neurol 1985, 17:573-577.
19. Volicer L., Frijters D.H., Van der Steen J.T. Relationship between symptoms of depression and agitation in nursing home residents with dementia. Int J Geriatr Psychiatry 2011, doi:10.1002/gps.2800.
20. Conn D.K., Seitz D.P. Advances in the treatment of psychiatric disorders in long-term care homes. Curr Opin Psychiatry 2010, 23:516-521.
21. Luttenberger K, Donath C, Uter W, et al. Effects of multimodal nondrug therapy on dementia symptoms and need for care in nursing home residents with degenerative dementia: A randomized-controlled study with 6-month followup. J Am Geriatr Soc; doi:10.1111/j.1532-5415.2012.03938.x.
22. Woods B., Aguirre E., Spector A.E., et al. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012, 2:CD005562.
23. Pollock B.G., Mulsant B.H., Rosen J., et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry 2002, 159:460-465.
24. Finkel S.I., Mintzer J.E., Dysken M., et al. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. Int J Geriatr Psychiatry 2004, 19:9-18.
25. Lyketsos C.G., DelCampo L., Steinberg M., et al. Treating depression in Alzheimer disease-Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS. Arch Gen Psychiatry 2003, 60:737-746.
26. Weintraub D., Rosenberg P.B., Drye L.T., et al. Sertraline for the treatment of depression in Alzheimer disease: Week-24 outcomes. Am J Geriatr Psychiatry 2012, 18:332-340.
27. Kozel F.A., Trivedi M.H., Wisniewski S.R., et al. Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry 2008, 16:58-64.
28. Papakostas G.I., Shelton R.C., Smith J., et al. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: A meta-analysis. J Clin Psychiatry 2007, 68:826-831.
29. Volicer L, Van der Steen JT, Frijters D. Underdiagnosis and undertreatment of depression in nursing home residents. Europ Geriatr Med, in press.
30. Hanlon J.T., Handler S.M., Castle N.G. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc 2010, 11:320-324.